Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis

Molecular and Cellular Neuroscience

Volumn 68, Issue , 2015, Pages 284-292

  Li, Heng ^a   Wang, Cong Cong ^a   Zhang, Min ^a   Li, Xiao Li ^a   Zhang, Peng ^a   Yue, Long Tao ^a   Miao, Shuai ^b   Wang, Shan ^a   Liu, Ying ^a   Li, Yan Bin ^a   Duan, Rui Sheng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dendritic cells; Experimental autoimmune myasthenia gravis; Follicular helper T cells; Humoral immunity; Regulatory B cells; Statin

Indexed keywords

ATORVASTATIN; B7 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 10; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; CHOLINERGIC RECEPTOR; HLA ANTIGEN CLASS 2; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; FEMALE; GERMINAL CENTER; HELPER CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; LEWIS RAT; METABOLISM; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; PATHOPHYSIOLOGY; TIME FACTOR;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; ATORVASTATIN CALCIUM; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNITY, HUMORAL; INTERLEUKINS; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 84940479304     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.08.010     Document Type: Article

References (60)

1. Baggi F., Annoni A., Ubiali F., Milani M., Longhi R., Scaioli W., Cornelio F., Mantegazza R., Antozzi C. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats. J. Immunol. 2004, 172:2697-2703.
2. Berrih-Aknin S., Frenkian-Cuvelier M., Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J. Autoimmun. 2014, 48-49:143-148.
3. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
4. Carter R.H., Myers R. Germinal center structure and function: lessons from CD19. Semin. Immunol. 2008, 20:43-48.
5. Carter N.A., Vasconcellos R., Rosser E.C., Tulone C., Munoz-Suano A., Kamanaka M., Ehrenstein M.R., Flavell R.A., Mauri C. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 2011, 186:5569-5579.
6. Crotty S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29:621-663.
7. Dienz O., Eaton S.M., Bond J.P., Neveu W., Moquin D., Noubade R., Briso E.M., Charland C., Leonard W.J., Ciliberto G., Teuscher C., Haynes L., Rincon M. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 2009, 206:69-78.
8. Duan R.S., Adikari S.B., Huang Y.M., Link H., Xiao B.G. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Neurobiol. Dis. 2004, 16:461-467.
9. Dubois B., Massacrier C., Vanbervliet B., Fayette J., Briere F., Banchereau J., Caux C. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 1998, 161:2223-2231.
10. Emmanouilidis N., Guo Z., Dong Y., Newton-West M., Adams A.B., Lee E.D.H., Wang J., Pearson T.C., Larsen C.P., Newell K.A. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells. Transplantation 2006, 81:455-462.
11. Ettinger R., Kuchen S., Lipsky P.E. The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 2008, 223:60-86.
12. Evans M., Rees A. The myotoxicity of statins. Curr. Opin. Lipidol. 2002, 13:415-420.
13. Fields R.C., Osterholzer J.J., Fuller J.A., Thomas E.K., Geraghty P.J., Mule J.J. Comparative analysis of murine dendritic cells derived from spleen and bone marrow. J. Immunother. 1998, 21:323-339.
14. Gale J., Danesh-Meyer H.V. Statins can induce myasthenia gravis. J. Clin. Neurosci. 2014, 21:195-197.
15. Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat. Rev. Immunol. 2006, 6:358-370.
16. Hussain S., Delovitch T.L. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 2007, 179:7225-7232.
17. Iorio R., Damato V., Alboini P.E., Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol. 2014.
18. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003, 19:225-234.
19. Kessel A., Haj T., Peri R., Snir A., Melamed D., Sabo E., Toubi E. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 2012, 11:670-677.
20. Kotlarz D., Zietara N., Milner J.D., Klein C. Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency. Curr. Opin. Pediatr. 2014, 26:704-712.
21. Le Panse R., Bismuth J., Cizeron-Clairac G., Weiss J.M., Cufi P., Dartevelle P., De Rosbo N.K., Berrih-Aknin S. Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 2010, 43:401-412.
22. Lennon V.A., Lindstrom J.M., Seybold M.E. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 1975, 141:1365-1375.
23. Li X.-L., Liu Y., Cao L.-L., Li H., Yue L.-T., Wang S., Zhang M., Li X.-H., Dou Y.-C., Duan R.-S. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines. Mol. Cell. Neurosci. 2013, 56:85-95.
24. Li Y., Rauniyar V.K., Yin W.F., Hu B., Ouyang S., Xiao B., Yang H. Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis. Neurol. Sci. 2014, 35:29-34.
25. Lo-Man R. Regulatory B cells control dendritic cell functions. Immunotherapy 2011, 3:19-20.
26. Luo C., Li Y., Liu W., Feng H., Wang H., Huang X., Qiu L., Ouyang J. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J. Neuroimmunol. 2013, 256:55-61.
27. Ma Y., Chen Z., Zou Y., Ge J. Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the PI3K/Akt/Nrf 2 pathway. Oxidative Med. Cell. Longev. 2014, 2014:148798.
28. Ma C.S., Suryani S., Avery D.T., Chan A., Nanan R., Santner-Nanan B., Deenick E.K., Tangye S.G. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol. Cell Biol. 2009, 87:590-600.
29. Ma J., Zhu C., Ma B., Tian J., Baidoo S.E., Mao C., Wu W., Chen J., Tong J., Yang M., Jiao Z., Xu H., Lu L., Wang S. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin. Dev. Immunol. 2012, 2012:1-7.
30. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol. Rev. 2011, 241:206-227.
31. Matsushita T., Horikawa M., Iwata Y., Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 2010, 185:2240-2252.
32. Mauri C., Blair P.A. Regulatory B cells in autoimmunity: developments and controversies. Nat. Rev. Rheumatol. 2010, 6:636-643.
33. Mauri C., Ehrenstein M.R. The 'short' history of regulatory B cells. Trends Immunol. 2008, 29:34-40.
34. Meraouna A., Cizeron-Clairac G., Panse R.L., Bismuth J., Truffault F., Tallaksen C., Berrih-Aknin S. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006, 108:432-440.
35. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8:475-490.
36. Morva A., Lemoine S., Achour A., Pers J.O., Youinou P., Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012, 119:106-114.
37. Noh G., Lee J.H. Regulatory B cells and allergic diseases. Allerg. Asthma Immunol. Res. 2011, 3:168-177.
38. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y.H., Dong C. Bcl6 mediates the development of T follicular helper cells. Science 2009, 325:1001-1005.
39. Oh S.J., Dhall R., Young A., Morgan M.B., Lu L., Claussen G.C. Statins may aggravate myasthenia gravis. Muscle Nerve 2008, 38:1101-1107.
40. Purvin V., Kawasaki A., Smith K.H., Kesler A. Statin-associated myasthenia gravis: report of 4 cases and review of the literature. Medicine 2006, 85:82-85.
41. Qian L., Qian C., Chen Y., Bai Y., Bao Y., Lu L., Cao X. Regulatory dendritic cells program B cells to differentiate into CD19hiFcgammaIIbhi regulatory B cells through IFN-beta and CD40L. Blood 2012, 120:581-591.
42. Schmitt N., Morita R., Bourdery L., Bentebibel S.E., Zurawski S.M., Banchereau J., Ueno H. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 2009, 31:158-169.
43. Shaw J., Wang Y.H., Ito T., Arima K., Liu Y.J. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood 2010, 115:3051-3057.
44. Simpson N., Gatenby P.A., Wilson A., Malik S., Fulcher D.A., Tangye S.G., Manku H., Vyse T.J., Roncador G., Huttley G.A., Goodnow C.C., Vinuesa C.G., Cook M.C. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010, 62:234-244.
45. Sims G.P., Shiono H., Willcox N., Stott D.I. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 2001, 167:1935-1944.
46. Sun F., Ladha S.S., Yang L., Liu Q., Shi S.X.-Y., Su N., Bomprezzi R., Shi F.-D. Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve 2014, 49:487-494.
47. Ueno H., Schmitt N., Palucka A.K., Banchereau J. Dendritic cells and humoral immunity in humans. Immunol. Cell Biol. 2010, 88:376-380.
48. Victora G.D., Nussenzweig M.C. Germinal centers. Annu. Rev. Immunol. 2012, 30:429-457.
49. Vinuesa C.G., Tangye S.G., Moser B., Mackay C.R. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 2005, 5:853-865.
50. Vogelzang A., McGuire H.M., Yu D., Sprent J., Mackay C.R., King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008, 29:127-137.
51. Volchenkov R., Karlsen M., Jonsson R., Appel S. Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scand. J. Immunol. 2013, 77:246-254.
52. Wei Y., Zheng D., Li X., Zhou W., Qian Y., Ming C., Shi B. Infusion of dendritic cells carrying donor lymphocytes treated with 8-methoxypsoralen and ultraviolet a light induces CD19+ IL-10+ regulatory B cells and promotes skin allograft survival. Transplant. Proc. 2014, 46:3641-3646.
53. Xie X., Mu L., Yao X., Li N., Sun B., Li Y., Zhan X., Wang X., Kang X., Wang J., Liu Y., Zhang Y., Wang G., Wang D., Liu X., Kong Q., Li H. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles. Clin. Immunol. 2013, 148:162-176.
54. Xin N., Fu L., Shao Z., Guo M., Zhang X., Zhang Y., Dou C., Zheng S., Shen X., Yao Y., Wang J., Wang J., Cui G., Liu Y., Geng D., Xiao C., Zhang Z., Dong R. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice. Mol. Cell. Neurosci. 2014, 58:85-94.
55. Xu H., Li X.L., Yue L.T., Li H., Zhang M., Wang S., Wang C.C., Duan R.S. Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1(+) cells. J. Neuroimmunol. 2014, 269:28-37.
56. Yang M., Deng J., Liu Y., Ko K.H., Wang X., Jiao Z., Wang S., Hua Z., Sun L., Srivastava G., Lau C.S., Cao X., Lu L. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am. J. Pathol. 2012, 180:2375-2385.
57. Zhang X., Liu S., Chang T., Xu J., Zhang C., Tian F., Sun Y., Song C., Yi W., Lin H., Li Z., Yang K. Intrathymic Tfh/B cells interaction leads to ectopic GCs formation and anti-AChR antibody production: central role in triggering MG occurrence. Mol. Neurobiol. 2014.
58. Zhang M., Zhou Y., Guo J., Li H., Tian F., Gong L., Wang X., Lan M., Li Z., Zhang W. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma. Exp. Neurol. 2014, 254:200-205.
59. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
60. Zhu C., Ma J., Liu Y., Tong J., Tian J., Chen J., Tang X., Xu H., Lu L., Wang S. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 2012, 97:943-950.